{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:36:56Z","timestamp":1762508216580},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00774-020-01139-5","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T22:03:27Z","timestamp":1599948207000},"page":"230-236","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Relationship between parathyroid hormone and renin\u2013angiotensin\u2013aldosterone system in hemodialysis patients with secondary hyperparathyroidism"],"prefix":"10.1007","volume":"39","author":[{"given":"Keiji","family":"Kono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"1139_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","volume":"17","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy (2013) Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial 17:221\u2013228","journal-title":"Ther Apher Dial"},{"key":"1139_CR2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","volume":"11","author":"N Kimata","year":"2007","unstructured":"Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S, Akizawa T, Saito A, Asano Y, Kurokawa K, Pisoni RL, Port FK (2007) Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int 11:340\u2013348","journal-title":"Hemodial Int"},{"key":"1139_CR3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2015.72","volume":"88","author":"H Komaba","year":"2015","unstructured":"Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350\u2013359","journal-title":"Kidney Int"},{"key":"1139_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913\u2013921","journal-title":"Clin J Am Soc Nephrol"},{"key":"1139_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/1744-9987.12679","volume":"22","author":"H Fujii","year":"2018","unstructured":"Fujii H (2018) Association between parathyroid hormone and cardiovascular disease. Ther Apher Dial 22:236\u2013241","journal-title":"Ther Apher Dial"},{"key":"1139_CR6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2013.02.014","volume":"165","author":"AJ van Ballegooijen","year":"2013","unstructured":"van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA (2013) Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. Am Heart J 165:655\u2013664","journal-title":"Am Heart J"},{"key":"1139_CR7","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1093\/ndt\/gfm370","volume":"22","author":"G Coen","year":"2007","unstructured":"Coen G, Manni M, Mantella D, Pierantozzi A, Balducci A, Condo S, DiGuilio S, Yancovie L, Lippi B, Manca S, Morosetti M, Pellegrino L, Simonetti G, Gallucci MT, Splendiani G (2007) Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Nephrol Dial Transplant 22:3262\u20133267","journal-title":"Nephrol Dial Transplant"},{"key":"1139_CR8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","volume":"31","author":"S Pilz","year":"2010","unstructured":"Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammar TB, Marz W (2010) Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 31:1591\u20131598","journal-title":"Eur Heart J"},{"key":"1139_CR9","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1681\/ASN.2012040390","volume":"23","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Cravedi P, Remuzzi G (2012) Mechanisms and treatment of CKD. J Am Soc Nephrol 23:1917\u20131928","journal-title":"J Am Soc Nephrol"},{"key":"1139_CR10","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","volume":"345","author":"KT Weber","year":"2001","unstructured":"Weber KT (2001) Aldosterone in congestive heart failure. N Engl J Med 345:1689\u20131697","journal-title":"N Engl J Med"},{"key":"1139_CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","volume":"63","author":"A Tomaschitz","year":"2014","unstructured":"Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, Gaksch M, Grubler M, Fahrleitner-Pammer A, Mrak P, Toplak H, Kraigher-Krainer E, Marz W, Pilz S (2014) Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism 63:20\u201331","journal-title":"Metabolism"},{"key":"1139_CR12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijcard.2015.03.062","volume":"184","author":"A Tomaschitz","year":"2015","unstructured":"Tomaschitz A, Pilz S, Rus-Machan J, Meinitzer A, Brandenburg VM, Scharnagl H, Kapl M, Grammar T, Ritz E, Horina JH, Kleber ME, Pieske B, Kraigher-Krainer E, Hartaigh BO, Toplak H, van Ballegooijen AJ, Amrein K, Fahrleitner-Pammer A, Marz W (2015) Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk. Int J Cardiol 184:710\u2013716","journal-title":"Int J Cardiol"},{"key":"1139_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247\u2013288","journal-title":"Ther Apher Dial"},{"key":"1139_CR14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2215\/CJN.03490807","volume":"3","author":"H Moriya","year":"2008","unstructured":"Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake T, Kobayashi S (2008) Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol 3:416\u2013422","journal-title":"Clin J Am Soc Nephrol"},{"key":"1139_CR15","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstrom","year":"2009","unstructured":"Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K, Arnlov J (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765\u20132771","journal-title":"Circulation"},{"key":"1139_CR16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","volume":"44","author":"A Lishmanov","year":"2012","unstructured":"Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A (2012) Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 44:541\u2013547","journal-title":"Int Urol Nephrol"},{"key":"1139_CR17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI110137","volume":"67","author":"E Bogin","year":"1981","unstructured":"Bogin E, Massry SG, Harary I (1981) Effect of parathyroid hormone on rat heart cells. J Clin Invest 67:1215\u20131227","journal-title":"J Clin Invest"},{"key":"1139_CR18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfn686","volume":"24","author":"FG Graciolli","year":"2009","unstructured":"Graciolli FG, Neves KR, dos Reis LM, Graciolli RG, Noronha IL, Moyses RM, Jorgetti V (2009) Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. Nephrol Dial Transplant 24:1416\u20131421","journal-title":"Nephrol Dial Transplant"},{"key":"1139_CR19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2169\/internalmedicine.46.0269","volume":"46","author":"H Fujii","year":"2007","unstructured":"Fujii H, Kim JI, Abe T, Umezu M, Fukagawa M (2007) Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients. Intern Med 46:1507\u20131512","journal-title":"Intern Med"},{"key":"1139_CR20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1380543","volume":"138","author":"L Kovacs","year":"1998","unstructured":"Kovacs L, Goth MI, Szabolcs I, Dohan O, Ferencz A, Szilagyi G (1998) Th effect of surgical treatment on secondary hyperaldosteronism and relativ hyperinsulinemia in primary hyperparathyroidism. Eur J Endocrinol 138:543\u2013547","journal-title":"Eur J Endocrinol"},{"key":"1139_CR21","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","volume":"97","author":"S Pilz","year":"2012","unstructured":"Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, Marz W, Pieber TR, Tomaschitz A (2012) Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. J Clin Endocrinol Metab 97:E75\u2013E79","journal-title":"J Clin Endocrinol Metab"},{"key":"1139_CR22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10157-011-0534-x","volume":"16","author":"F Koiwa","year":"2012","unstructured":"Koiwa F, Komukai D, Hirose M, Yoshimura A, Ando R, Sakaguchi T, Komatsu Y, Shinoda T, Inaguma D, Joki N, Nishida H, Ikeda M, Shigematsu T (2012) Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients. Clin Exp Nephrol 16:130\u2013135","journal-title":"Clin Exp Nephrol"},{"key":"1139_CR23","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1177\/1470320314548868","volume":"16","author":"L Gao","year":"2015","unstructured":"Gao L, Wang Z, Feng S, Jiang S, Ouyang H, Shi Y, Shen H (2015) The effect of renin-angiotensin system inhibitors on intact parathyroid hormone levels in peritoneal dialysis patients. J Renin Angiotensin Aldosterone Syst 16:1260\u20131265","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1139_CR24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","volume":"58","author":"C Maniero","year":"2011","unstructured":"Maniero C, Fassina A, Guzzardo V, Lenzini L, Amadori G, Pelizzo MR, Gomez-Sanchez C, Rossi GP (2011) Primary hyperparathyroidism with concurrent primary aldosteronism. Hypertension 58:341\u2013346","journal-title":"Hypertension"},{"key":"1139_CR25","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1210\/jc.2019-00143","volume":"104","author":"L Lenzini","year":"2019","unstructured":"Lenzini L, Prisco S, Vanderriele PE, Lerco S, Torresan F, Maiolino G, Seccia TM, Lacobone M, Rossi GP (2019) PTH modulation by aldosterone and angiotensin II is blunted in hyperaldosteronism and rescued by adrenalectomy. J Clin Endocrinol Metab 104:3726\u20133734","journal-title":"J Clin Endocrinol Metab"},{"key":"1139_CR26","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1152\/ajpheart.00477.2004","volume":"287","author":"VS Chhokar","year":"2004","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT (2004) Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol 287:2023\u20132026","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1139_CR27","first-page":"988","volume":"75","author":"FD Grant","year":"1992","unstructured":"Grant FD, Mandel SJ, Brown EM, Williams GH, Seely EW (1992) Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 75:988\u2013992","journal-title":"J Clin Endocrinol Metab"},{"key":"1139_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/cs0840011","volume":"84","author":"C Saussine","year":"1993","unstructured":"Saussine C, Judes C, Massfelder T, Musso MJ, Simeoni U, Hannedouche T, Helwig JJ (1993) Stimulatory action of parathyroid hormone on renin secretion in vitro: a study using isolated rat kidney, isolated rabbit glomeruli and superfused dispersed rat juxtaglomerular cells. Clin Sci 84:11\u201319","journal-title":"Clin Sci"},{"key":"1139_CR29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/endo-129-3-1233","volume":"129","author":"JJ Helwig","year":"1991","unstructured":"Helwig JJ, Musso MJ, Judes C, Nickols GA (1991) Parathyroid hormone and calcium: interactions in the control of renin secretion in the isolated, nonfiltering rat kidney. Endocrinology 129:1233\u20131242","journal-title":"Endocrinology"},{"key":"1139_CR30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1113\/jphysiol.2003.049890","volume":"552","author":"Pontus B Persson","year":"2003","unstructured":"Persson Pontus B (2003) Renin: origin, secretion and synthesis. J Physiol 552:667\u2013671","journal-title":"J Physiol"},{"key":"1139_CR31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.1991.113","volume":"39","author":"N von Lutterotti","year":"1991","unstructured":"von Lutterotti N, Gulmi F, Marion D, Darrocott E, Vaughan Jr, Laragh JH, Sealey JE (1991) Increased plasma prorenin but not renin after bilateral ureteral ligation in dogs. Kidney Int 39:901\u2013908","journal-title":"Kidney Int"},{"key":"1139_CR32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/01.HYP.30.2.259","volume":"30","author":"SA Katz","year":"1997","unstructured":"Katz SA, Opsahl JA, Lunzer MM, Forbis LM, Hirsch AT (1997) Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension 30:259\u2013266","journal-title":"Hypertension"},{"key":"1139_CR33","first-page":"115","volume":"55","author":"D Grekas","year":"2001","unstructured":"Grekas D, Kalevrosoglou I, Karamouzis M, Geropoulou E, Kabouris H, Tourkantonis A (2001) Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Clin Nephrol 55:115\u2013120","journal-title":"Clin Nephrol"},{"key":"1139_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1291\/hypres.29.597","volume":"29","author":"K Kohagura","year":"2006","unstructured":"Kohagura K, Higashiuesato Y, Ishiki T, Yoshi S, Ohya Y, Iseki K, Takishita S (2006) Plasma aldosterone in hypertensive patients on chronic hemodialysis: distribution, determinants and impact on survival. Hypertens Res 29:597\u2013604","journal-title":"Hypertens Res"},{"key":"1139_CR35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/jhh.2014.125","volume":"29","author":"A Vaidya","year":"2015","unstructured":"Vaidya A, Brown JM, Williams JS (2015) The renin-angiotensin-aldosterone system and calcium-regulatory hormones. J Hum Hypertens 29:515\u2013521","journal-title":"J Hum Hypertens"},{"key":"1139_CR36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","volume":"13","author":"LL Schierbeck","year":"2011","unstructured":"Schierbeck LL, Jensen TS, Bang U, Jensen G, Kober L, Jensen JE (2011) Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure. Eur Heart J 13:626\u2013632","journal-title":"Eur Heart J"},{"key":"1139_CR37","first-page":"145828","volume":"2015","author":"D Santoro","year":"2015","unstructured":"Santoro D, Caccamo D, Lucisano S, Buemi M, Sebekova K, Teta D, De Nicola L (2015) Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system. Biomed Res Int 2015:145828","journal-title":"Biomed Res Int"},{"key":"1139_CR38","doi-asserted-by":"crossref","first-page":"F1168","DOI":"10.1152\/ajprenal.00606.2015","volume":"310","author":"CP Kovesdy","year":"2016","unstructured":"Kovesdy CP, Quarles LD (2016) FGF23 from bench to bedside. Am J Physiol Renal Physiol 310:F1168\u2013F1174","journal-title":"Am J Physiol Renal Physiol"},{"key":"1139_CR39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","volume":"470","author":"B Zhang","year":"2016","unstructured":"Zhang B, Umbach AT, Chen H, Yan J, Fakhri H, Fajol A, Salker MS, Spichtig D, Daryadel A, Wagner CA, Foller M, Lang F (2016) Up-regulation of FGF23 release by aldosterone. Biochem Biophys Res Commun 470:384\u2013390","journal-title":"Biochem Biophys Res Commun"},{"key":"1139_CR40","doi-asserted-by":"crossref","first-page":"11298","DOI":"10.1038\/s41598-017-10140-4","volume":"7","author":"S Slavic","year":"2017","unstructured":"Slavic S, Ford K, Modert M, Becirovic A, Handschuh S, Baierl A, Katica N, Zeitz U, Erben RG, Andrukhova O (2017) Genetic ablation of fgf23 or klotho does not modulate experimental heart hypertrophy induced by pressure overload. Sci Rep 7:11298","journal-title":"Sci Rep"},{"key":"1139_CR41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10157-018-1680-1","volume":"23","author":"H Fujii","year":"2019","unstructured":"Fujii H, Watanabe K, Kono K, Goto S, Watanabe S, Nishi S (2019) Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats. Clin Exp Nephrol 23:589\u2013596","journal-title":"Clin Exp Nephrol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-020-01139-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T18:41:19Z","timestamp":1723574479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-020-01139-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1139"],"URL":"https:\/\/doi.org\/10.1007\/s00774-020-01139-5","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional medical ethical committee (No. 180016). The study was conducted in line with the 1964 Helsinki Declaration principles.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}